COST vs UTI
Costco vs Universal Technical Institute, Inc. — AI-powered side-by-side comparison
VS
UTI
Universal Technical Institute, Inc.
53
Watch
| Metric | COST | UTI |
|---|
| AI Score |
64
|
53
|
| Price |
$944.09
|
$25.56
|
| P/E Ratio |
47.43×
|
40.60×
|
| ROE |
27.8%
|
19.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
12.9%
|
61.5%
|
| Debt / Equity |
0.25×
|
1.04×
|
| Dividend Yield |
0.6%
|
0.0%
|
| RSI (14) |
55.2
|
20.6
|
| Beta |
0.86
|
1.236
|
| Expected Upside |
+1.2%
|
—
|
AI Committee View
Current Innellis committee reasoning for COST versus UTI.
COST leads by 11 points.
COST scores 64/100 (Buy) versus UTI at 53/100 (Watch).
COST Committee View
67% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.25) -- balance sheet can absorb a shock. The main limiting factor is p/e of 47.6 is expensive by classic value standards. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 28.3% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 47.6 is expensive by classic value standards — Value
- Price-to-book of 14.3x prices in significant intangible value — Value
- 2 consecutive earnings misses -- execution concerns — Growth
UTI Committee View
67% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Technical Analyst remains cautious — rsi at 21 is in oversold territory (could mean either capitulation or a bounce setup). This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Low leverage (debt-to-equity 0.27) -- balance sheet can absorb a shock — Risk
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 37.4 is moderate-to-rich — Value
- Price-to-book of 5.4x prices in significant intangible value — Value
- EPS declining -25.9% YoY despite any revenue growth — Growth